BioSherpa, LLC develops the BioSherpa Specimen Transport System, a biofilm-reducing diagnostic agent designed to help laboratories culture infectious pathogens even after patients have received antibiotics. The system grew from infectious-disease research conducted by founders Tom Cumbo and Destin Radder in Nepal and Peru, and was later developed with physician and former Army officer Christopher Hutson. Its research includes cases where BioSherpa STS identified pathogens missed by standard collection methods, including a case involving three days of effective antibiotic treatment.
Biomeme, IncSince 2012, Biomeme has built its identity around decentralizing molecular diagnostics, developing field-ready testing for people who need biological answers outside a central laboratory. The Philadelphia company works with military and first-responder organizations as well as healthcare and research users, and makes its systems on site in a 40,000-square-foot vertically integrated facility.541714PHILADELPHIA, PA
Biaera Technologies, LLCFounded in 2003 by former USAMRIID aerosol research director Dr. Justin M. Hartings, Hagerstown-based Biaera Technologies develops fully automated, turnkey and custom inhalation systems for laboratory infectious-disease research. Its patented aerosol-control platforms integrate laboratory equipment and exposure systems, supporting research programs at government, military, university and independent laboratories worldwide.HAGERSTOWN, MD
Tetracore, IncFor more than 20 years, Rockville-based Tetracore, Inc. has developed diagnostic reagents, assays, and instruments that detect infectious diseases and biothreat agents. Its work spans human and animal health, domestic preparedness, and forensic biology, including the T-COR 8 portable PCR thermocycler and the BioThreat Alert testing platform. Tetracore’s quality system is certified to ISO 13485 and ISO 9001, with laboratories accredited to ISO/IEC 17025.ROCKVILLE, MD
LIV ProcessPhiladelphia-area biotech LIV Process develops a patented visualization system that makes otherwise invisible Clostridioides difficile spores visible on healthcare surfaces in real time. Its water-based solution binds to proteins on the spores and fluoresces under a dedicated light, helping hospital environmental-services teams target cleaning and verify that contamination has been removed. Founded by inventor and longtime medical-product executive Michael McIntyre, the company operates from headquarters in Ardmore with research and development in Cambridge.325998ARDMORE, PA